Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, laryngeal squamous cell carcinoma, neoplasm, oropharynx squamous cell carcinoma, squamous cell carcinoma	Recruiting	Not stated	2026-07-31		NCT06947668

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Erlangen-Nürnberg Medical School	47

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Universitätsklinikum Erlangen, Strahlenklinik	Erlangen	Germany	4